Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Eli Lilly stacking scientists in San Diego as part of R&D growth spurt
BioPharma Dive
Fri, 07/24/15 - 03:43 pm
Tags:
Eli Lilly, R&D, San Diego
Lilly sales inch up on demand for animal health, new drugs
Yahoo/Reuters
Thu, 07/23/15 - 09:15 am
Tags:
Eli Lilly, earnings
Lilly says drug slows Alzheimer's in patients with mild disease
Yahoo/Reuters
Wed, 07/22/15 - 08:42 am
Tags:
Eli Lilly, Alzheimer's disease, solanezumab
The Pharma Industry Thinks It Finally Has a Fix for Migraines
Yahoo/Bloomberg
Tue, 07/21/15 - 10:17 am
Tags:
migraines, Teva Pharmaceutical, Amgen, Eli Lilly, Alder Biopharma, CGRPs
Will Trial Results for Lilly and Biogen Alzheimer’s Drugs be Hard to Forget?
WSJ Pharmalot
Mon, 07/20/15 - 11:01 pm
Tags:
Eli Lilly, Biogen, clinical trials, Alzheimer's disease, aducanumab, solanezumab
6 Big-Cap Drugmakers Reporting Earnings Next Week
Investors.com
Sat, 07/18/15 - 11:00 am
Tags:
earnings, Novartis, Bristol-Myers Squibb, Eli Lilly, Valeant Pharmaceuticals, AbbVie, Biogen
Alzheimer’s Drug Is a Big Bet for Lilly
WSJ Online
Sat, 07/18/15 - 10:35 am
Tags:
Eli Lilly, Alzheimer's disease, solanezumab
Lilly and Biogen prep make-or-break Alzheimer's data amid an amyloid renaissance
Fierce Biotech
Fri, 07/17/15 - 12:06 pm
Tags:
Eli Lilly, Biogen, Alzheimer's disease
Lilly's Alimta gets rating boost in update to ASCO's drug scorecard
Fierce Pharma
Wed, 07/15/15 - 12:23 pm
Tags:
Eli Lilly, Alimta, ASCO, lung cancer
Lilly Diabetes Launches Android Version of Glucagon Mobile Application for Those Who Support People with Diabetes
Yahoo
Wed, 07/15/15 - 09:20 am
Tags:
Eli Lilly, diabetes, Android, smartphones, mobile apps
3 Top Big Pharmaceutical Stocks With Upcoming Catalysts
24/7 Wall St
Tue, 07/14/15 - 11:44 am
Tags:
AbbVie, Humira, Cyramza, Eli Lilly, generics, Evista, Cymbalta, Pfizer, Ibrance
FDA support for Lilly cancer drug comes down to unmet needs vs side effects
BioPharma Dive
Sat, 07/11/15 - 10:34 am
Tags:
FDA, Eli Lilly, necitumumab, non-small cell lung cancer
FDA panel says benefits outweigh risks for Lilly's lung-cancer drug
Medical Marketing and Media
Thu, 07/9/15 - 09:51 pm
Tags:
FDA, advisory panels, Eli Lilly, necitumumab, lung cancer
Eli Lilly preps a familiar case for FDA review of a marginal cancer drug
Fierce Biotech
Mon, 07/6/15 - 12:16 pm
Tags:
FDA, Eli Lilly, necitumumab, squamous non-small cell lung cancer
AAIC Is Coming: Here's What To Expect, Biogen And Eli Lilly Investors
Yahoo/Benzinga
Sun, 07/5/15 - 10:57 am
Tags:
AAIC, Biogen, Eli Lilly, aducanumab, solanezumab
Actelion creates €30M vax startup, Immunocore expands Lilly deal, Cell Therapy seeks PhIII ally
Fierce Biotech
Thu, 07/2/15 - 11:12 am
Tags:
Immunocore, Actelion, vaccines, Eli Lilly, Cell Therapy Group
Lilly is Fined by Brazil for ‘Sham’ Litigation Over a Cancer Drug Patent
WSJ Pharmalot
Mon, 06/29/15 - 07:57 pm
Tags:
Eli Lilly, Brazil, Gemzar, patents
Lilly's Alzheimer's Game
Seeking Alpha
Sun, 06/28/15 - 11:32 am
Tags:
Eli Lilly, Alzheimer's disease, solanezumab
Deep in ‘the Cave,' Lilly's CEO Decided Alzheimer's Drug's Fate
Yahoo/Bloomberg
Fri, 06/26/15 - 11:45 am
Tags:
Eli Lilly, Alzheimer's disease, John Lechleiter
Eli Lilly faces August trials in suits over Cymbalta withdrawal symptoms
Fierce Pharma Marketing
Thu, 06/25/15 - 11:38 am
Tags:
Eli Lilly, Cymbalta, withdrawal symptoms, antidepressants

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.